Basics

Basics-1

Marinella Astuto Editor 2009 The success of the fellowship program developed by the School of Medicine of Catania in collaboration with McGill University of Montreal led to the organization of the first masterclass in anesthesia, intensive care and pain in neonates and children, held in September 2007 in Catania with a selected group of participants.

Continue reading →

Malignant Mesothelioma

Malignant Mesothelioma-1

Andrea Tannapfel (Editor) 2011 Malignant mesothelioma is a rare and aggressive tumor arising from the mesothelium. Pleural, peritoneal, and pericardial mesothelioma are possible entities according to the site of origin. Diffuse malignant mesothelioma is strongly associated with exposure to asbestos and was first referred by Selikoff in 1965 as a “signal tumor” because of its close association with occupational […]

Continue reading →

Induction Chemotherapy

Induction Chemotherapy-1

Karl Reinhard Aigner • Frederick Oscar Stephens (Editors) 2011 Integrated Treatment Programs for Locally Advanced Cancers Induction chemotherapy is chemotherapy used as the first modality of an integrated treatment program. It can be an effective method of reducing locally advanced or aggressive primary cancers to improve their prospects of cure by planned follow-up surgery and/or radiotherapy.

Continue reading →

Evolution of Radiation Oncology at Massachusetts General Hospital

Evolution of Radiation Oncology at Massachusetts General Hospital-1

Herman D. Suit · Jay S. Loeffler 2011 The undisguised goal of the Massachusetts General Hospital [MGH] Department of Radiation Oncology is to work intensively to progressively and substantially increase the proportion of patients who are free of tumor and of treatment-related morbidity. There is acute awareness of the high incidence of cancer and the fact that we […]

Continue reading →

Bortezomib in the Treatment of Multiple Myeloma

Bortezomib in the Treatment of Multiple Myeloma-1

Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson Editors 2011 The proteasome is a highly conserved multicatalytic protease that is responsible for cellular protein turnover, and several therapeutic agents have been developed that specifically target the proteasome. This truly targeted therapy has significantly altered the management of patients with Multiple Myeloma and improved survival.

Continue reading →

Urological Cancers

Urological Cancers-1

Jonathan Waxman (Ed) 2005 Urological cancer constitutes approximately 30% of all cancer occurring in the Third and Second Worlds. In the main, these diseases are caused by environmental factors, such as diet and smoking, and it is hoped that action to regulate the influence of these environmental pathogens will lead to a decreased incidence over the next two or […]

Continue reading →

UPDATES IN DIAGNOSTIC PATHOLOGY

Updates in Diagnostic Pathology-1

Edited by David C. Chhieng Gene P. Siegal 2005 By November 1997, we had built the corpus of a Division of Anatomic Pathology (AP) Department at the University of Alabama at Birmingham which had begun some 7 years earlier. It had become evident, however, that the breadth, depth and quality of our faculty remained mostly unknown outside the […]

Continue reading →